12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

Accelr8 Technology, Novartis deal

The parties extended to Sept. 30 the evaluation period for a deal under which Novartis' Novartis Vaccines and Diagnostics Inc. subsidiary is evaluating Accelr8's BACcel rapid diagnostic system in identifying the type and quantity of...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >